You got it biopharm! It is so obvious. The industry is spending billions on trying to prove that each of their various PS receptors are the answer when PPHM's PS-targeting of the ligand makes all of the others either obsolete or in need of the PPHM combination with them. We have the GLOBAL upstream master checkpoint "covered"!
Damn... I say Fargo was because PS Targeting is "highly on target" and PS Targeting remains the target for IO combo's
Mother nature is smiling on us and on those who have cancer and other life threatening diseases.
We know the facts so your FUD (Fear Uncertainty and Doubt) is useless here.